Video 7 November 2012

26th IFPMA assembly panel discussion II


Geneva, October 31, 2012

Panel II: “Creative Innovation: Addressing Key Research Gaps”

Ama de-Graft Aikins, Visiting Fellow, London School of Economics, Health
Francis Gurry, Director General, World Intellectual Property Organization
Trevor Mundel, President, Global Health Program, Gates Foundation
Dhaval D Patel, Head, Novartis Institutes for BioMedical Research Europe, Novartis
Bernard Pécoul, Executive Director, Drugs for Neglected Diseases Initiative
Ulf Wiinberg, President and CEO, Lundbeck


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster